Clinicians can use the Frontotemporal Amination Screening Test (FAST) to identify treatable complications in Alzheimer's disease patients. Early speech loss may indicate focal cerebral pathology like stroke, not typical disease progression.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background: